Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
32.20    -0.10 (-0.31%)
Bid:
32.20
Ask:
33.10
Spread: 0.90 (2.795%)
Market Cap: £88.12m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

Land Based Gaming Machine Licensing Agreement

28 Apr 2016 07:39

RNS Number : 6136W
Gaming Realms PLC
28 April 2016
 

 

Gaming Realms plc

 

("Gaming Realms", the "Company" or the "Group")

 

Gaming Realms signs land based gaming machine licensing agreement

 

Slingo IP agreement with Scientific Games Corporation

 

 

Gaming Realms announces that it has signed a strategic, five-year licensing agreement with Scientific Games Corporation (NASDAQ: SGMS), one of the leading providers of gambling products and services to lottery and gaming organisations. The gaming machine manufacturer will have exclusive rights to produce and distribute Slingo® branded slot machines to casinos and related properties on a worldwide basis.

 

Under the terms of the licence, Scientific Games will develop new slot games for traditional gaming machines, video lottery terminals, and on-property handheld devices. The agreement includes a minimum guaranteed royalty stream to Gaming Realms payable within the first two years. The agreement is an expansion of Scientific Games' existing licence to produce Slingo® branded scratch lottery tickets. This is one of the most successful licensing arrangements in the lottery industry, selling over $1 billion dollars' worth of tickets across 36 U.S States and three international markets.

 

Commenting on the agreement, Patrick Southon, CEO, said:

 

"Following on from the success of our printed lottery products partnership with Scientific Games, we are delighted with the opportunity to bring Slingo to slot machines in casinos around the world with a market leader." 

 

The new licence is an important next step in Gaming Realms' long-term strategy to extend Slingo® into markets adjacent to the Group's core mobile gaming business, and comes on the back of the three-year social gaming agreement with Zynga Inc. announced in January this year. Both licences will deliver high-margin revenue streams over their respective periods.

 

 

Contacts:

 

Gaming Realms

Patrick Southon, CEO

Mark Segal, FD

+44 (0) 845 123 3773

 

 

Cenkos Securities (Nomad and Broker)

Max Hartley (Nomad)

Julian Morse (Broker)

 

 

+44 (0) 20 7397 8900

Yellow Jersey PR

Charles Goodwin

Aidan Stanley

+44 (0) 7747 788 221

 

 

About Gaming Realms

 

Gaming Realms creates and publishes innovative real money and social games for mobile, with operations in the UK and U.S. Through its market leading mobile platform and unique IP and brands, Gaming Realms is bringing together media, entertainment and gaming assets in new game formats. The Gaming Realms management team includes accomplished entrepreneurs and experienced executives from a wide range of leading gaming and media companies.

 

About Scientific Games Corporation

 

Scientific Games Corporation (NASDAQ: SGMS) is a leading developer of technology-based products and services and associated content for worldwide gaming, lottery and interactive markets. The Company's portfolio includes gaming machines, game content and systems; table games products and utilities; instant and draw-based lottery games; server-based lottery and gaming systems; sports betting technology; loyalty and rewards programs; and interactive content and services. For more information, please visit http://www.scientificgames.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKFDNABKKOQB
Date   Source Headline
2nd Jun 20263:38 pmRNSTotal Voting Rights and Share Capital
2nd Jun 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares & Treasury Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20262:42 pmRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNS-RInvestor Presentation
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Results 2025
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.